Calliditas Therapeutics AB (publ) Cash and Cash Equivalents 2011-2026 | CALT

Annual Cash and Cash Equivalents Calliditas Therapeutics AB (publ)

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
956 M	996 M	754 M	646 M	-	-	-	-	-	-	-

All numbers in SEK currency

Indicator range from annual reports

Maximum	Minimum	Average
996 M	646 M	838 M

Quarterly Cash and Cash Equivalents Calliditas Therapeutics AB (publ)

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	847 M	825 M	956 M	-	709 M	867 M	996 M	-	1.46 B	729 M	754 M	-	-	-	646 M	-	-	-	57.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in SEK currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.46 B	57.4 M	804 M

Cash and Cash Equivalents of other stocks in the Drug manufacturers industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	5.89 M	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	2.56 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	12.1 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.08 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	37.2 M	-	-	$ 754 M	USA
DURECT Corporation DRRX	28.4 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	55.3 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	778 M	-	-	$ 28.9 M	Irlanda
Catalent CTLT	289 M	-	-	$ 11.5 B	USA
Harrow Health HROW	72.9 M	$ 41.51	2.41 %	$ 1.53 B	USA
Athenex ATNX	30.4 M	-	-23.39 %	$ 1.76 M	USA
Cumberland Pharmaceuticals CPIX	18 M	$ 4.14	-1.19 %	$ 58.2 M	USA
Avadel Pharmaceuticals plc AVDL	51.4 M	-	-	$ 2.06 B	France
Pacira BioSciences PCRX	277 M	$ 25.04	-1.77 %	$ 1.16 B	USA
Jupiter Wellness JUPW	2.28 M	-	-	$ 33.6 M	USA
HEXO Corp. HEXO	83.2 M	-	2.45 %	$ 38.1 M	Canada
Solid Biosciences SLDB	59.9 M	$ 7.13	-1.86 %	$ 624 M	USA
Sonoma Pharmaceuticals SNOA	5.37 M	$ 1.15	4.55 %	$ 1.43 M	USA
Evoke Pharma EVOK	4.74 M	-	-	$ 36.6 M	USA
Bausch Health Companies BHC	947 M	$ 5.57	-2.62 %	$ 2.03 B	Canada
Tilray TLRY	207 M	$ 6.13	-1.76 %	$ 3.79 B	Canada
Canopy Growth Corporation CGC	114 M	$ 1.13	1.35 %	$ 122 M	Canada
Veru VERU	24.9 M	$ 2.26	0.44 %	$ 305 M	USA
Aurora Cannabis ACB	138 M	$ 3.46	0.58 %	$ 86.3 M	Canada
Lannett Company LCI	87.9 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	24.6 M	$ 1.43	1.06 %	$ 402 M	Canada
Evolus EOLS	53.8 M	$ 5.36	-0.65 %	$ 346 M	USA
Sundial Growers SNDL	252 M	$ 1.42	4.04 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	112 M	$ 8.32	1.09 %	$ 426 M	USA
Organogenesis Holdings ORGO	136 M	$ 2.44	3.83 %	$ 321 M	USA
Neoleukin Therapeutics NLTX	104 M	-	-	$ 193 M	Canada
cbdMD YCBD	2.45 M	$ 0.82	-5.79 %	$ 3.54 M	USA
ProPhase Labs PRPH	9.11 M	-	-	$ 5.07 M	USA
Radius Health RDUS	112 M	-	-	$ 1.42 B	USA
Assertio Holdings ASRT	10.2 M	$ 18.42	-0.08 %	$ 118 M	USA
PetIQ PETQ	116 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	3.5 M	$ 7.68	2.13 %	$ 303 M	USA
Recro Pharma REPH	8.1 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	73.7 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	21.3 M	$ 0.98	5.87 %	$ 48.9 M	USA
PLx Pharma PLXP	69.4 M	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	992 M	$ 15.03	0.6 %	$ 18 B	USA
Zomedica Corp. ZOM	9.02 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	50.6 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	10.7 M	$ 0.87	-1.19 %	$ 31.3 M	USA
Tricida TCDA	21.1 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	345 K	$ 0.57	5.35 %	$ 2.45 M	China
TherapeuticsMD TXMD	7.48 M	$ 2.05	0.25 %	$ 23.7 M	USA